Source: Eur Respir J 2007; 30: 843-847



Rating:

Share or cite this content

Citations should be made in the following way:
Computed tomographic screening for lung cancer: individualising the benefit of the screening. Eur Respir J 2007; 30: 843-847

Member's Comments

No comment yet.

Related content which might interest you: Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Improving NLST criteria for lung cancer screening Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Impact of PET scan on staging and management of lung cancer patients in Indian scenario Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Association with emphysema on computed tomography and lung cancer in smokers Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 National lung cancer tissue diagnosis targets: Are they achievable? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Lung cancer: screening and staging Source: Eur Respir Monogr 2015; 70: 47-59 Year: 2015 Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Variation in lung cancer diagnosis in England Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Lung cancer revisited – CT scan and bronchoscopy concordance after treatment Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Diagnosing lung cancer: Choosing the best for your patient Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Evaluation of spirometry test as monitoring tool in lung cancer patients Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Assessment of nutritional status in patients with primary lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014